NR0B1 and neoplasm: Furthermore, our results indicate reductions in the tumour-to-plasma ratios in R954-treated mice (30% and 69% reduction at 1 h and 4 h after injection, respectively), emphasising the specific accumulation of [111In]In-DOTA-Ahx-R954 under in vivo conditions.